ACTU · Actuate Therapeutics, Inc. · Executive Compensation
$0.30
+0.01 (+1.75%)
At close · Nov 11
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$7.26M
Shares
24.01M
Volume · Nov 11
94.93K
Avg daily vol (3M)
422.63K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Daniel M. Schmitt | President and Chief Executive Officer | $2,166,522 |
| Andrew P. Mazar | Ph. D. Chief Operating Officer | $1,419,569 |
| Paul Lytle | Chief Financial Officer | $1,006,361 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Daniel M. Schmitt | President and Chief Executive Officer | $5,578,616 |
| Paul Lytle | Chief Financial Officer | $1,896,096 |
| Andrew P. Mazar | Ph. D. Chief Operating Officer | $675,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Andrew P. Mazar | Ph. D. Chief Operating Officer | $666,112 |
| Daniel M. Schmitt | President and Chief Executive Officer | $520,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Martin H. Huber, MD | Class III director | Appointed | 2026-05-06 |
| Amy Ronneberg | Director | Appointed | 2024-08-14 |
| Roger Sawhney | Director | Appointed | 2024-08-14 |
| Jason Keyes | Director | Appointed | 2024-08-14 |
Leadership
- Daniel M. Schmitt CEO, Board Member
- Paul Lytle CFO
- Andrew P. Mazar COO
- Aaron G.L. Fletcher Board Member
- Amy Ronneberg Board Member
- Dr. Dan Zabrowski Board Member
- Dr. Roger Sawhney Board Member
- Jason Keyes Board Member
- Martin H. Huber, MD Board Member
- Roger Sawhney Board Member
- Todd Thomson Board Member
Key facts
CIK
1652935
CUSIP
005083100
13F (30d)
18 filings
18 filers
Visit website
Investor relations